The effect of caffeine on human quality of life: Myths and realities
PDF

Keywords

Caffeine
Coffee
Cardiovascular diseases
Cognitive function
Energy drinks

How to Cite

Moya, M. O. C., Pernas, G. G., Ruiz, E. S., Abreu, D. G., Cano, E. P., Cabrera, L. H., & Ramos, N. P. (2026). The effect of caffeine on human quality of life: Myths and realities. SAP Primary Care, 2, 142. https://doi.org/10.62486/pc2026142

Abstract

Introduction: caffeine is the most widely consumed psychoactive agent globally. Historically surrounded by controversies, current scientific evidence reveals a complex coexistence of potential benefits and risks dependent on dosage and individual characteristics. Objective: to analyze the impact of caffeine consumption on people's quality of life, critically examining myths and realities in light of the most recent scientific evidence. Methods: a descriptive and narrative literature review was conducted through standardized searches in academic databases (PubMed, Scopus, SciELO) for publications between 2020 and 2026, selecting and qualitatively analyzing clinical and epidemiological evidence. Development: caffeine metabolism varies based on polymorphisms of the CYP1A2 gene. Moderate consumption (3 to 5 cups daily) disproves the myth of arrhythmogenic risk and is inversely associated with the risk of type 2 diabetes, dementia, liver diseases (steatosis and cirrhosis), and hepatocellular carcinoma, while also serving as an ergogenic aid in sports. However, high intake increases the risk of acute myocardial infarction and causes adverse effects such as insomnia, anxiety, and dependence. In pregnant women, intake is dose-dependently associated with a higher risk of small-for-gestational-age newborns. Furthermore, energy drinks represent a distinct cardiovascular and behavioral risk for children and adolescents. Conclusions: moderate caffeine consumption can be part of a healthy lifestyle in adults. However, recommendations must be individualized based on genetic, physiological, and safety factors, especially in vulnerable populations.
PDF

References

Van Dam RM, Hu FB, Willett WC. Coffee, Caffeine, and Health. Campion EW, editor. N Engl J Med. 23 de julio de 2020;383(4):369-78. doi:10.1056/NEJMra1816604

Saimaiti A, Zhou DD, Li J, Xiong RG, Gan RY, Huang SY, et al. Dietary sources, health benefits, and risks of caffeine. Crit Rev Food Sci Nutr. 17 de noviembre de 2023;63(29):9648-66. doi:10.1080/10408398.2022.2074362

Fredholm BB. Notes on the History of Caffeine Use. En: Methylxanthines [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2011 [citado 4 de junio de 2026]. p. 1-9. (Handbook of Experimental Pharmacology). Disponible en: http://link.springer.com/10.1007/978-3-642-13443-2_1 doi:10.1007/978-3-642-13443-2_1

Saraiva SM, Jacinto TA, Gonçalves AC, Gaspar D, Silva LR. Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies. Pharmaceuticals. 27 de julio de 2023;16(8):1067. doi:10.3390/ph16081067

Mitchell DC, Trout M, Smith R, Teplansky R, Lieberman HR. An update on beverage consumption patterns and caffeine intakes in a representative sample of the US population. Food Chem Toxicol. febrero de 2025;196:115237. doi:10.1016/j.fct.2025.115237

Park JJ, Han X, Potenza MN, Zhao Y. The effect of caffeine use in the relationship between gaming and sleep in adolescents: A mediation analysis. J Behav Addict. 30 de septiembre de 2025;14(3):1368-79. doi:10.1556/2006.2025.00076 PubMed PMID: 40928887; PubMed Central PMCID: PMC12490325.

Mitchell DC, Trout M, Smith R, Teplansky R, Lieberman HR. An update on beverage consumption patterns and caffeine intakes in a representative sample of the US population. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. febrero de 2025;196:115237. doi:10.1016/j.fct.2025.115237 PubMed PMID: 39778646.

Tripathi M, Singh BK, Liehn EA, Lim SY, Tikno K, Castano-Mayan D, et al. Caffeine prevents restenosis and inhibits vascular smooth muscle cell proliferation through the induction of autophagy. Autophagy. septiembre de 2022;18(9):2150-60. doi:10.1080/15548627.2021.2021494 PubMed PMID: 35012409; PubMed Central PMCID: PMC9466618.

Montalvo‐Alonso JJ, Del Val‐Manzano M, Martín‐Rivas I, Ferragut C, Valadés D, Pérez‐López A. CYP1A2 Genotype and the Ergogenic Effect of Acute Caffeine Intake on Muscular Strength and Endurance Performance in Trained Individuals. Scand J Med Sci Sports. febrero de 2026;36(2):e70214. doi:10.1111/sms.70214

Guo J, Zhu X, Badawy S, Ihsan A, Liu Z, Xie C, et al. Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2. Curr Drug Metab. 22 de marzo de 2021;22(1):40-9. doi:10.2174/1389200221999210101233135

Kim E jeong, Hoffmann TJ, Nah G, Vittinghoff E, Delling F, Marcus GM. Coffee Consumption and Incident Tachyarrhythmias: Reported Behavior, Mendelian Randomization, and Their Interactions. JAMA Intern Med. 1 de septiembre de 2021;181(9):1185. doi:10.1001/jamainternmed.2021.3616

Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation. J Am Coll Cardiol. enero de 2024;83(1):109-279. doi:10.1016/j.jacc.2023.08.017

Shaban EE, Elmelliti H, Shaban A, Shaban A, Elkandow A, Abdelrahim MG, et al. Coffee, caffeine, and cardiovascular health: navigating risks and benefits—an updated systematic review and meta-analysis. BMC Cardiovasc Disord. 7 de mayo de 2026. doi:10.1186/s12872-026-05693-0

Dewland TA, Van Dam RM, Marcus GM. Coffee and cardiovascular disease. Eur Heart J. 22 de septiembre de 2025;46(36):3546-54. doi:10.1093/eurheartj/ehaf421

Henn M, Glenn AJ, Willett WC, Martínez-González MA, Sun Q, Hu FB. Coffee Consumption, Additive Use, and Risk of Type 2 Diabetes—Results from 3 Large Prospective United States Cohort Studies. Am J Clin Nutr. marzo de 2025;121(3):695-702. doi:10.1016/j.ajcnut.2025.01.017

Mohamed AI, Erukainure OL, Salau VF, Islam MS. Impact of coffee and its bioactive compounds on the risks of type 2 diabetes and its complications: A comprehensive review. Diabetes Metab Syndr Clin Res Rev. julio de 2024;18(7):103075. doi:10.1016/j.dsx.2024.103075

Zhang Y, Liu Y, Li Y, Li Y, Gu X, Kang JH, et al. Coffee and Tea Intake, Dementia Risk, and Cognitive Function. JAMA. 17 de marzo de 2026;335(11):961. doi:10.1001/jama.2025.27259

Cornelis MC, Bennett DA, Weintraub S, Schneider JA, Morris MC. Caffeine Consumption and Dementia: Are Lewy Bodies the Link? Ann Neurol. junio de 2022;91(6):834-46. doi:10.1002/ana.26349

Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. julio de 2020;70(4):245-71. doi:10.3322/caac.21591

Yu J, Liang D, Li J, Liu Z, Zhou F, Wang T, et al. Coffee, Green Tea Intake, and the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies. Nutr Cancer. 2023;75(5):1295-308. doi:10.1080/01635581.2023.2178949 PubMed PMID: 37038314.

Khalifa R, Al‐Naamani K, Elbadry M, Zhang Y, Alswat K, El‐Kassas M. Protective Role of Coffee in Chronic Liver Disease: A Focus on Processing. J Viral Hepat. octubre de 2025;32(10):e70072. doi:10.1111/jvh.70072

Singal AK, Wong RJ, Dasarathy S, Abdelmalek MF, Neuschwander-Tetri BA, Limketkai BN, et al. ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease. Am J Gastroenterol. mayo de 2025;120(5):950-72. doi:10.14309/ajg.0000000000003379

Yh C, Yc C, Wj C. Age- and dose-specific effects of caffeine on sleep: A meta-analysis of controlled crossover trials. Sleep Med. diciembre de 2025;136. doi:10.1016/j.sleep.2025.106874 PubMed PMID: 41124973.

Nascimento AOD, Silva CECD, Silva MLD, Cunha KDC. The Effects of Caffeine on Anxiety Behavior in Healthy Individuals: A Systematic Review of the Literature. Stress Health. febrero de 2026;42(1):e70139. doi:10.1002/smi.70139

C L, L W, C Z, Z H, J T, J X, et al. Caffeine intake and anxiety: a meta-analysis. Front Psychol. 2 de enero de 2024;15. doi:10.3389/fpsyg.2024.1270246 PubMed PMID: 38362247.

Askari M, Bazshahi E, Payande N, Mobaderi T, Fahimfar N, Azadbakht L. Relationship between caffeine intake and small for gestational age and preterm birth: a dose-response meta-analysis. Crit Rev Food Sci Nutr. 6 de agosto de 2024;64(20):6942-52. doi:10.1080/10408398.2023.2177606

Gleason JL, Tekola-Ayele F, Sundaram R, Hinkle SN, Vafai Y, Buck Louis GM, et al. Association Between Maternal Caffeine Consumption and Metabolism and Neonatal Anthropometry: A Secondary Analysis of the NICHD Fetal Growth Studies-Singletons. JAMA Netw Open. 1 de marzo de 2021;4(3):e213238. doi:10.1001/jamanetworkopen.2021.3238 PubMed PMID: 33764424; PubMed Central PMCID: PMC7994948.

Rohweder R, De Oliveira Schmalfuss T, Dos Santos Borniger D, Ferreira CZ, Zanardini MK, Lopes GPTF, et al. Caffeine intake during pregnancy and adverse outcomes: An integrative review. Reprod Toxicol. enero de 2024;123:108518. doi:10.1016/j.reprotox.2023.108518

James JE. Maternal Caffeine Consumption and Pregnancy Outcomes. En: Bukiya AN, Ali DW, editores. Molecular Mechanisms and Lifelong Consequences of Prenatal Exposure to Psychoactive Substances [Internet]. Cham: Springer Nature Switzerland; 2026 [citado 4 de junio de 2026]. p. 303-36. (Advances in Experimental Medicine and Biology). Disponible en: https://link.springer.com/10.1007/978-3-032-12741-9_10 doi:10.1007/978-3-032-12741-9_10

Guest NS, VanDusseldorp TA, Nelson MT, Grgic J, Schoenfeld BJ, Jenkins NDM, et al. International society of sports nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2 de enero de 2021;18(1):1. doi:10.1186/s12970-020-00383-4

Stadheim HK, Stensrud T, Brage S, Jensen J. Caffeine Increases Exercise Performance, Maximal Oxygen Uptake, and Oxygen Deficit in Elite Male Endurance Athletes. Med Sci Sports Exerc. 1 de noviembre de 2021;53(11):2264-73. doi:10.1249/MSS.0000000000002704 PubMed PMID: 34033621.

Grgic J. Effects of Caffeine on Resistance Exercise: A Review of Recent Research. Sports Med. noviembre de 2021;51(11):2281-98. doi:10.1007/s40279-021-01521-x

Lowery LM, Anderson DE, Scanlon KF, Stack A, Escalante G, Campbell SC, et al. International society of sports nutrition position stand: coffee and sports performance. J Int Soc Sports Nutr. diciembre de 2023;20(1):2237952. doi:10.1080/15502783.2023.2237952 PubMed PMID: 37498180; PubMed Central PMCID: PMC10375938.

Berman NK, Honig S, Cronstein BN, Pillinger MH. The effects of caffeine on bone mineral density and fracture risk. Osteoporos Int. junio de 2022;33(6):1235-41. doi:10.1007/s00198-021-05972-w

Zhang S, Wu S, Xia B, He Q, Mi N, Zhao J, et al. Association of coffee and tea consumption with osteoporosis risk: A prospective study from the UK biobank. Bone. septiembre de 2024;186:117135. doi:10.1016/j.bone.2024.117135

Liu QP, Chai ST. Caffeine intake is inversely associated with osteoporosis risk based on cross-sectional and genetic evidence. Sci Rep. 1 de julio de 2025;15(1):20720. doi:10.1038/s41598-025-07916-4

Li GHY, Tang CM, Wu SM, Cheung CL. Causal association of genetically determined caffeine intake from tea or coffee with bone health: a two-sample Mendelian randomization study. Postgrad Med J. 22 de septiembre de 2024;100(1188):730-40. doi:10.1093/postmj/qgae051

Asoudeh F, Bagheri A, Larijani B, Esmaillzadeh A. Coffee consumption and caffeine intake in relation to risk of fractures: a systematic review and dose-response meta-analysis of observational studies. Crit Rev Food Sci Nutr. 6 de noviembre de 2023;63(28):9039-51. doi:10.1080/10408398.2022.2067114

Freeman AM, Morris PB, Aspry K, Gordon NF, Barnard ND, Esselstyn CB, et al. A Clinician’s Guide for Trending Cardiovascular Nutrition Controversies: Part II. J Am Coll Cardiol. 31 de julio de 2018;72(5):553-68. doi:10.1016/j.jacc.2018.05.030 PubMed PMID: 30049315.

Oberhoffer FS, Dalla-Pozza R, Jakob A, Haas NA, Mandilaras G, Li P. Energy drinks: effects on pediatric 24-h ambulatory blood pressure monitoring. A randomized trial. Pediatr Res. septiembre de 2023;94(3):1172-9. doi:10.1038/s41390-023-02598-y PubMed PMID: 37061642; PubMed Central PMCID: PMC10444612.

Menzel J, Spinka F, Pie MJ, Deichl A, Knüppel S, Ehlers A, et al. Chronic high consumption of energy drinks and cardiovascular risk in adolescents-results of the EDKAR-study. Eur J Epidemiol. noviembre de 2025;40(11):1355-68. doi:10.1007/s10654-025-01292-z PubMed PMID: 40847210; PubMed Central PMCID: PMC12696085.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 Maikro Osvaldo Chávez Moya, Gabriela González Pernas, Elizabeth Soler Ruiz, Dashiell González Abreu, Eirina Pernas Cano, Leodanis Hernández Cabrera, Neisy Pérez Ramos (Author)